184 related articles for article (PubMed ID: 25074384)
41. Inhibitory Effect of Tangeretin and Cardamonin on Human Intestinal SGLT1 Activity In Vitro and Blood Glucose Levels in Mice In Vivo.
Satsu H; Shibata R; Suzuki H; Kimura S; Shimizu M
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684383
[TBL] [Abstract][Full Text] [Related]
42. Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents.
Du F; Hinke SA; Cavanaugh C; Polidori D; Wallace N; Kirchner T; Jennis M; Lang W; Kuo GH; Gaul MD; Lenhard J; Demarest K; Ajami NJ; Liang Y; Hornby PJ
J Pharmacol Exp Ther; 2018 Jun; 365(3):676-687. PubMed ID: 29674332
[TBL] [Abstract][Full Text] [Related]
43. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2.
Kanwal A; Singh SP; Grover P; Banerjee SK
Anal Biochem; 2012 Oct; 429(1):70-5. PubMed ID: 22796500
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetic and pharmacodynamic modeling of the effect of an sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats.
Yamaguchi K; Kato M; Suzuki M; Asanuma K; Aso Y; Ikeda S; Ishigai M
Drug Metab Dispos; 2011 Oct; 39(10):1801-7. PubMed ID: 21712434
[TBL] [Abstract][Full Text] [Related]
45. Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study.
Peschard S; Raverdy V; Bauvin P; Goutchtat R; Touche V; Derudas B; Gheeraert C; Dubois-Chevalier J; Caiazzo R; Baud G; Marciniak C; Verkindt H; Oukhouya Daoud N; Le Roux CW; Lefebvre P; Staels B; Lestavel S; Pattou F
Diabetes; 2024 Jun; 73(6):983-992. PubMed ID: 38498375
[TBL] [Abstract][Full Text] [Related]
46. Inhibitor binding in the human renal low- and high-affinity Na+/glucose cotransporters.
Pajor AM; Randolph KM; Kerner SA; Smith CD
J Pharmacol Exp Ther; 2008 Mar; 324(3):985-91. PubMed ID: 18063724
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo antihyperglycemic effect of 2 amadori rearrangement compounds, arginyl-fructose and arginyl-fructosyl-glucose.
Ha KS; Jo SH; Kang BH; Apostolidis E; Lee MS; Jang HD; Kwon YI
J Food Sci; 2011 Oct; 76(8):H188-93. PubMed ID: 22417590
[TBL] [Abstract][Full Text] [Related]
48. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
[TBL] [Abstract][Full Text] [Related]
49. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
Fujita Y; Kojima H; Hidaka H; Fujimiya M; Kashiwagi A; Kikkawa R
Diabetologia; 1998 Dec; 41(12):1459-66. PubMed ID: 9867213
[TBL] [Abstract][Full Text] [Related]
50. Inhibitor binding mode and allosteric regulation of Na
Bisignano P; Ghezzi C; Jo H; Polizzi NF; Althoff T; Kalyanaraman C; Friemann R; Jacobson MP; Wright EM; Grabe M
Nat Commun; 2018 Dec; 9(1):5245. PubMed ID: 30532032
[TBL] [Abstract][Full Text] [Related]
51. Absorption of resveratrol by vascular endothelial cells through passive diffusion and an SGLT1-mediated pathway.
Chen ML; Yi L; Jin X; Xie Q; Zhang T; Zhou X; Chang H; Fu YJ; Zhu JD; Zhang QY; Mi MT
J Nutr Biochem; 2013 Nov; 24(11):1823-9. PubMed ID: 23927891
[TBL] [Abstract][Full Text] [Related]
52. Regulation of glucose transporter expression in human intestinal Caco-2 cells following exposure to an anthocyanin-rich berry extract.
Alzaid F; Cheung HM; Preedy VR; Sharp PA
PLoS One; 2013; 8(11):e78932. PubMed ID: 24236070
[TBL] [Abstract][Full Text] [Related]
53. Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
Fushimi N; Fujikura H; Shiohara H; Teranishi H; Shimizu K; Yonekubo S; Ohno K; Miyagi T; Itoh F; Shibazaki T; Tomae M; Ishikawa-Takemura Y; Nakabayashi T; Kamada N; Ozawa T; Kobayashi S; Isaji M
Bioorg Med Chem; 2012 Nov; 20(22):6598-612. PubMed ID: 23062824
[TBL] [Abstract][Full Text] [Related]
54. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats.
Li Y; Wen S; Kota BP; Peng G; Li GQ; Yamahara J; Roufogalis BD
J Ethnopharmacol; 2005 Jun; 99(2):239-44. PubMed ID: 15894133
[TBL] [Abstract][Full Text] [Related]
55. Estriol blunts postprandial blood glucose rise in male rats through regulating intestinal glucose transporters.
Yamabe N; Kang KS; Lee W; Kim SN; Zhu BT
Am J Physiol Endocrinol Metab; 2015 Mar; 308(5):E370-9. PubMed ID: 25516546
[TBL] [Abstract][Full Text] [Related]
56. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.
Gorboulev V; Schürmann A; Vallon V; Kipp H; Jaschke A; Klessen D; Friedrich A; Scherneck S; Rieg T; Cunard R; Veyhl-Wichmann M; Srinivasan A; Balen D; Breljak D; Rexhepaj R; Parker HE; Gribble FM; Reimann F; Lang F; Wiese S; Sabolic I; Sendtner M; Koepsell H
Diabetes; 2012 Jan; 61(1):187-96. PubMed ID: 22124465
[TBL] [Abstract][Full Text] [Related]
57. Polymer-phloridzin conjugates as an anti-diabetic drug that inhibits glucose absorption through the Na+/glucose cotransporter (SGLT1) in the small intestine.
Ikumi Y; Kida T; Sakuma S; Yamashita S; Akashi M
J Control Release; 2008 Jan; 125(1):42-9. PubMed ID: 18006167
[TBL] [Abstract][Full Text] [Related]
58. Identification of phlorizin binding domains in sodium-glucose cotransporter family: SGLT1 as a unique model system.
Raja M; Kinne RK
Biochimie; 2015 Aug; 115():187-93. PubMed ID: 26086341
[TBL] [Abstract][Full Text] [Related]
59. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
Arakawa K; Ishihara T; Oku A; Nawano M; Ueta K; Kitamura K; Matsumoto M; Saito A
Br J Pharmacol; 2001 Jan; 132(2):578-86. PubMed ID: 11159708
[TBL] [Abstract][Full Text] [Related]
60. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
Singh J; Kakkar P
Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
